Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Brainstorm Cell Therapeutics (BCLI)
NASDAQ:BCLI
RESEARCH TOOLSreports
Holding BCLI?
Track your performance easily
Brainstorm Cell Therapeutics (BCLI) Ownership Overview
26.00% Insiders
28.20% Mutual Funds
2.75% Other Institutional Investors
27.50% ETFs
15.55% Public Companies and
Individual Investors
The ownership structure of Brainstorm Cell Therapeutics (BCLI) stock is a mix of institutional, retail, and individual investors. Approximately 58.45% of the company’s stock is owned by Institutional Investors, 26.00% is owned by Insiders, and 15.55% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 02, 2024 | Chaim Lebovits President & Ceo | xxxxxxxxxxxxx | $11119 |
| Jul 24, 2024 | Ibrahim B. Dagher Chief Medical Officer | xxxxxxxxxxxxx | $22050 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,462,032 | Institution | 27.50% | 1,754,438 | |
| 1,462,032 | Institution | 27.50% | 1,754,438 | |
| 423,435 | Insider | 7.97% | 508,122 | |
| 3,060,000 | Insider | 6.25% | 3,672,000 | |
| 214,349 | Insider | 4.03% | 257,219 | |
| 190,000 | Insider | 3.57% | 228,000 | |
| 126,969 | Insider | 2.39% | 152,363 | |
| 65,246 | Insider | 1.23% | 78,295 | |
| 33,748 | Institution | 0.63% | 40,498 | |
| 30,000 | Insider | 0.56% | 36,000 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,462,032 | Institution | 27.50% | 1,754,438 | |
| 33,748 | Institution | 0.63% | 40,498 | |
| 3,152 | Institution | 0.06% | 3,782 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,061,018 | Institution | 19.96% | 244,352 | |
| 401,014 | Institution | 7.54% | 92,354 |
FAQ
Who Owns Brainstorm Cell Therapeutics (BCLI)?
According to the latest TipRanks data, approximately 2.75% of the company's stock is held by institutional investors, 26.00% is held by insiders, and 15.55% is held by retail investors.
What percentage of Brainstorm Cell Therapeutics (BCLI) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.75% of Brainstorm Cell Therapeutics (BCLI) stock is held by institutional investors.
What percentage of Brainstorm Cell Therapeutics (BCLI) stock is held by retail investors?
According to the latest TipRanks data, approximately 15.55% of Brainstorm Cell Therapeutics (BCLI) stock is held by retail investors.
Who owns the most shares of Brainstorm Cell Therapeutics (BCLI)?
Vanguard owns the most shares of Brainstorm Cell Therapeutics (BCLI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.